日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/02/21 | 4,941 | 4,955 | 4,896 | 4,931 | -19 | -0.4% | 195,200 |
| 2024/02/20 | 4,972 | 4,982 | 4,945 | 4,950 | -12 | -0.2% | 231,300 |
| 2024/02/19 | 5,049 | 5,050 | 4,946 | 4,962 | -87 | -1.7% | 251,400 |
| 2024/02/16 | 4,938 | 5,049 | 4,891 | 5,049 | +161 | +3.3% | 284,700 |
| 2024/02/15 | 4,912 | 4,922 | 4,827 | 4,888 | -44 | -0.9% | 345,900 |
| 2024/02/14 | 4,942 | 4,998 | 4,857 | 4,932 | -11 | -0.2% | 396,300 |
| 2024/02/13 | 5,100 | 5,119 | 4,917 | 4,943 | -226 | -4.4% | 896,700 |
| 2024/02/09 | 5,145 | 5,213 | 5,110 | 5,169 | +22 | +0.4% | 279,900 |
| 2024/02/08 | 5,120 | 5,170 | 5,086 | 5,147 | +37 | +0.7% | 221,600 |
| 2024/02/07 | 5,161 | 5,166 | 5,067 | 5,110 | -21 | -0.4% | 249,000 |
| 2024/02/06 | 5,225 | 5,225 | 5,117 | 5,131 | -107 | -2% | 211,400 |
| 2024/02/05 | 5,189 | 5,281 | 5,185 | 5,238 | +75 | +1.5% | 247,400 |
| 2024/02/02 | 5,182 | 5,212 | 5,160 | 5,163 | -26 | -0.5% | 195,600 |
| 2024/02/01 | 5,182 | 5,212 | 5,149 | 5,189 | -46 | -0.9% | 222,900 |
| 2024/01/31 | 5,200 | 5,238 | 5,145 | 5,235 | +1 | ±0% | 262,100 |
| 2024/01/30 | 5,252 | 5,316 | 5,224 | 5,234 | -7 | -0.1% | 354,800 |
| 2024/01/29 | 5,287 | 5,330 | 5,212 | 5,241 | -10 | -0.2% | 244,900 |
| 2024/01/26 | 5,249 | 5,298 | 5,230 | 5,251 | -17 | -0.3% | 280,900 |
| 2024/01/25 | 5,283 | 5,321 | 5,193 | 5,268 | -30 | -0.6% | 203,400 |
| 2024/01/24 | 5,216 | 5,327 | 5,207 | 5,298 | +118 | +2.3% | 358,900 |
| 2024/01/23 | 5,192 | 5,255 | 5,165 | 5,180 | +60 | +1.2% | 181,100 |
| 2024/01/22 | 5,126 | 5,145 | 5,093 | 5,120 | +19 | +0.4% | 138,900 |
| 2024/01/19 | 5,112 | 5,131 | 5,071 | 5,101 | -9 | -0.2% | 273,200 |
| 2024/01/18 | 5,087 | 5,130 | 5,084 | 5,110 | +1 | ±0% | 209,200 |
| 2024/01/17 | 5,154 | 5,177 | 5,088 | 5,109 | -48 | -0.9% | 288,800 |
| 2024/01/16 | 5,185 | 5,217 | 5,145 | 5,157 | -45 | -0.9% | 190,300 |
| 2024/01/15 | 5,286 | 5,286 | 5,177 | 5,202 | -56 | -1.1% | 216,300 |
| 2024/01/12 | 5,253 | 5,278 | 5,197 | 5,258 | +69 | +1.3% | 377,900 |
| 2024/01/11 | 5,290 | 5,290 | 5,175 | 5,189 | -51 | -1% | 375,900 |
| 2024/01/10 | 5,225 | 5,274 | 5,204 | 5,240 | -8 | -0.2% | 308,900 |
| 2024/01/09 | 5,246 | 5,269 | 5,189 | 5,248 | +56 | +1.1% | 198,600 |
| 2024/01/05 | 5,255 | 5,256 | 5,162 | 5,192 | -62 | -1.2% | 244,000 |
| 2024/01/04 | 5,066 | 5,258 | 5,031 | 5,254 | +258 | +5.2% | 435,600 |
| 2023/12/29 | 4,981 | 5,006 | 4,962 | 4,996 | +1 | ±0% | 159,700 |
| 2023/12/28 | 5,000 | 5,019 | 4,936 | 4,995 | +44 | +0.9% | 147,500 |
| 2023/12/27 | 4,875 | 4,959 | 4,875 | 4,951 | +76 | +1.6% | 181,300 |
| 2023/12/26 | 4,890 | 4,908 | 4,839 | 4,875 | -21 | -0.4% | 195,300 |
| 2023/12/25 | 4,930 | 4,941 | 4,883 | 4,896 | -10 | -0.2% | 115,900 |
| 2023/12/22 | 4,899 | 4,959 | 4,892 | 4,906 | +60 | +1.2% | 176,000 |
| 2023/12/21 | 4,899 | 4,910 | 4,837 | 4,846 | -105 | -2.1% | 202,600 |
| 2023/12/20 | 4,981 | 5,028 | 4,950 | 4,951 | -20 | -0.4% | 225,500 |
| 2023/12/19 | 4,937 | 4,976 | 4,888 | 4,971 | +46 | +0.9% | 289,200 |
| 2023/12/18 | 4,798 | 4,933 | 4,763 | 4,925 | +57 | +1.2% | 383,900 |
| 2023/12/15 | 4,975 | 5,018 | 4,825 | 4,868 | -166 | -3.3% | 724,000 |
| 2023/12/14 | 5,098 | 5,118 | 4,963 | 5,034 | -33 | -0.7% | 352,000 |
| 2023/12/13 | 5,058 | 5,090 | 5,001 | 5,067 | -29 | -0.6% | 452,900 |
| 2023/12/12 | 5,120 | 5,186 | 5,085 | 5,096 | +38 | +0.8% | 365,500 |
| 2023/12/11 | 5,008 | 5,075 | 4,995 | 5,058 | +48 | +1% | 441,700 |
| 2023/12/08 | 5,080 | 5,089 | 4,992 | 5,010 | -106 | -2.1% | 484,700 |
| 2023/12/07 | 5,222 | 5,222 | 5,108 | 5,116 | -124 | -2.4% | 349,700 |
51～
100
件表示中 / 3450件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 441,300円 | +2.0% | +11.5% | 2.81% | 11.43倍 | 1.41倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 参天薬 | 154,800円 | +8.2% | - | 2.13% | 19.06倍 | 1.83倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| 久光薬 | 383,500円 | +7.3% | -3.8% | 2.35% | 18.38倍 | 1.10倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| ツムラ | 369,200円 | +8.5% | -4.5% | 1.90% | 17.31倍 | 1.06倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| ペプチド | 196,500円 | +21.9% | +134.3% | 0.00% | 34.89倍 | 6.31倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
